Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study

Before And After ◽

PROGNOSTIC VALUE OF ANEMIA IN NEWLY DIAGNOSED METASTATIC PROSTATE CANCER: A MULTIVARIATE ANALYSIS OF SOUTHWEST ONCOLOGY GROUP STUDY 8894

The Journal of Urology ◽

10.1097/01.ju.0000147771.92104.83 ◽

2004 ◽

Vol 172 (6 Part 1) ◽

pp. 2213-2217 ◽

Cited By ~ 17

Author(s):

TOMASZ M. BEER ◽

CATHERINE M. TANGEN ◽

LISA B. BLAND ◽

IAN M. THOMPSON ◽

E. DAVID CRAWFORD

Keyword(s):

Prostate Cancer ◽

Multivariate Analysis ◽

Prognostic Value ◽

Metastatic Prostate Cancer ◽

Newly Diagnosed ◽

Oncology Group ◽

Oncology Group Study ◽

A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a southwest oncology group study

Journal of Neuro-Oncology ◽

10.1007/bf01050266 ◽

1993 ◽

Vol 15 (1) ◽

pp. 75-77 ◽

Cited By ~ 116

Author(s):

J. Wendall Goodwin ◽

John Crowley ◽

Harmon J. Eyre ◽

Benjamin Stafford ◽

Kurt A. Jaeckle ◽

...

Keyword(s):

Phase Ii ◽

Oncology Group ◽

Oncology Group Study ◽

Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: A Southwest Oncology Group study

International Journal of Cancer ◽

10.1002/(sici)1097-0215(20000320)89:2<111::aid-ijc2>3.0.co;2-w ◽

2000 ◽

Vol 89 (2) ◽

pp. 111-117 ◽

Cited By ~ 201

Author(s):

Richard M. Elledge ◽

Stephanie Green ◽

Reginald Pugh ◽

D. Craig Allred ◽

Gary M. Clark ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Binding Assay ◽

Metastatic Breast ◽

Ligand Binding Assay ◽

Oncology Group ◽

Oncology Group Study ◽

Immuno Histochemistry

A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas. A southwest oncology group study

Cancer ◽

10.1002/1097-0142(19951201)76:11<2248::aid-cncr2820761111>3.0.co;2-y ◽

1995 ◽

Vol 76 (11) ◽

pp. 2248-2252 ◽

Cited By ~ 51

Author(s):

Stanley P. Balcerzak ◽

Jacqueline Benedetti ◽

Geoffrey R. Weiss ◽

Ronald B. Natale

Keyword(s):

Soft Tissue ◽

Phase Ii ◽

Phase Ii Trial ◽

Soft Tissue Sarcomas ◽

Oncology Group ◽

Oncology Group Study ◽

Influence of chest radiotherapy in frequency and patterns of chest relapse in disseminated small cell lung carcinoma. A Southwest oncology group study

Cancer ◽

10.1002/1097-0142(19821001)50:7<1266::aid-cncr2820500708>3.0.co;2-0 ◽

1982 ◽

Vol 50 (7) ◽

pp. 1266-1272 ◽

Cited By ~ 24

Author(s):

Joaquin G. Mira ◽

Robert B. Livingston ◽

Terrence N. Moore ◽

Timothy Chen ◽

Frank Batley ◽

...

Keyword(s):

Lung Carcinoma ◽

Small Cell Lung Carcinoma ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Cell Lung Carcinoma ◽

Oncology Group Study ◽

Phase II trial of PN401, 5-FU, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach: A Southwest Oncology Group study

Investigational New Drugs ◽

10.1007/s10637-006-9244-8 ◽

2006 ◽

Vol 24 (6) ◽

pp. 537-542 ◽

Cited By ~ 7

Author(s):

James H. Doroshow ◽

Sheryl McCoy ◽

John S. Macdonald ◽

Brian F. Issell ◽

Taral Patel ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Adenocarcinoma ◽

Oncology Group ◽

Oncology Group Study ◽

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances ◽

Chemotherapy alone versus combined modality therapy for Stage III Hodgkin’s disease: A five-year follow-up of a Southwest Oncology Group study (SWOG-7518) USA

10.1007/978-1-4613-2607-6_36 ◽

1985 ◽

pp. 345-351 ◽

Cited By ~ 1

Author(s):

P. N. Grozea ◽

E. J. Depersio ◽

C. A. Coltman ◽

C. J. Fabian ◽

F. S. Morrison ◽

...

Keyword(s):

Hodgkin's Disease ◽

Hodgkin’S Disease ◽

Combined Modality Therapy ◽

Stage Iii ◽

Oncology Group ◽

Oncology Group Study ◽

Combined Modality ◽

Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG-9500)

American Journal of Hematology ◽

10.1002/ajh.20994 ◽

2007 ◽

Vol 82 (12) ◽

pp. 1056-1062 ◽

Cited By ~ 17

Author(s):

Stephen H. Petersdorf ◽

Cathryn Rankin ◽

David R. Head ◽

Howard R. Terebelo ◽

Cheryl L. Willman ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Myeloid Leukemia ◽

High Dose ◽

Oncology Group ◽

Oncology Group Study ◽

High Dose Cytarabine ◽

Acute Myeloid

A phase II multi-institutional trial of low-dose N-(phosphonacetyl)-L-aspartate and high-dose 5-fluorouracil as a short-term infusion in the treatment of adenocarcinoma of the pancreas. A southwest oncology group study

Cancer ◽

10.1002/1097-0142(19910115)67:2<363::aid-cncr2820670208>3.0.co;2-h ◽

1991 ◽

Vol 67 (2) ◽

pp. 363-366 ◽

Cited By ~ 17

Author(s):

Louise M. Morrell ◽

Ardalan Bach ◽

Stephen P. Richman ◽

Phyllis Goodman ◽

Thomas R. Fleming ◽

...

Keyword(s):

Phase Ii ◽

Low Dose ◽

High Dose ◽

Oncology Group ◽

Short Term ◽

Oncology Group Study ◽

Adenocarcinoma Of The Pancreas

Phase II evaluation of mitoxantrone in advanced pancreatic carcinoma: A Southwest Oncology Group study

Investigational New Drugs ◽

10.1007/bf00216928 ◽

1990 ◽

Vol 8 (1) ◽

pp. 77-80 ◽

Cited By ~ 5

Author(s):

Sarah A. Taylor ◽

Thomas Fleming ◽

Daniel D. Von Hoff ◽

Joseph D. McCracken ◽

Ronald M. Bukowski ◽

...

Keyword(s):

Pancreatic Carcinoma ◽

Phase Ii ◽

Oncology Group ◽

Oncology Group Study ◽

Advanced Pancreatic Carcinoma